Cargando…
ApoE mimetic peptide decreases Aβ production in vitro and in vivo
BACKGROUND: Apolipoprotein E (apoE) is postulated to affect brain Aβ levels through multiple mechanisms--by altering amyloid precursor protein (APP) processing, Aβ degradation, and Aβ clearance. We previously showed that an apoE-derived peptide containing a double repeat of the receptor-binding regi...
Autores principales: | Minami, S Sakura, Cordova, Antoinette, Cirrito, John R, Tesoriero, Joseph A, Babus, Lenard W, Davis, Gary C, Dakshanamurthy, Sivanesan, Turner, R Scott, Pak, Daniel TS, Rebeck, G William, Paige, Mikell, Hoe, Hyang-Sook |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890633/ https://www.ncbi.nlm.nih.gov/pubmed/20406479 http://dx.doi.org/10.1186/1750-1326-5-16 |
Ejemplares similares
-
ApoE Receptor 2 Regulates Synapse and Dendritic Spine Formation
por: Dumanis, Sonya B., et al.
Publicado: (2011) -
Apolipoprotein E decreases tau kinases and phospho-tau levels in primary neurons
por: Hoe, Hyang-Sook, et al.
Publicado: (2006) -
Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease
por: Minami, S Sakura, et al.
Publicado: (2010) -
IntegralVac: A Machine Learning-Based Comprehensive Multivalent Epitope Vaccine Design Method
por: Suri, Sadhana, et al.
Publicado: (2022) -
A New Hybrid Neural Network Deep Learning Method for Protein–Ligand Binding Affinity Prediction and De Novo Drug Design
por: Limbu, Sarita, et al.
Publicado: (2022)